[HTML][HTML] Myopia, its prevalence, current therapeutic strategy and recent developments: A Review
Myopia is a widespread and complex refractive error in which a person's ability to see
distant objects clearly is impaired. Its prevalence rate is increasing worldwide, and as per …
distant objects clearly is impaired. Its prevalence rate is increasing worldwide, and as per …
[HTML][HTML] Role of 7-methylxanthine in myopia prevention and control: a mini-review
L Lai, K Trier, DM Cui - International Journal of Ophthalmology, 2023 - ncbi.nlm.nih.gov
Myopia is becoming increasingly common. By 2050 around 10% of the world's population is
expected to be highly myopic (<-5 diopters) and therefore particularly at risk of suffering from …
expected to be highly myopic (<-5 diopters) and therefore particularly at risk of suffering from …
Sub-chronic and chronic toxicity evaluation of 7-methylxanthine: a new molecule for the treatment of myopia
Myopia (nearsightedness) is a vision disorder with a blurring of far objects, affect millions
worldwide. 7-methylxanthine (7-MX) is a molecule that is presently under clinical …
worldwide. 7-methylxanthine (7-MX) is a molecule that is presently under clinical …
[HTML][HTML] Systemic 7-methylxanthine in retarding axial eye growth and myopia progression: a 36-month pilot study
K Trier, S Munk Ribel-Madsen, D Cui… - Journal of ocular biology …, 2008 - Springer
Abstract The adenosine antagonist 7-methylxanthine (7-mx) works against myopia in animal
models. In a clinical trial, 68 myopic children (mean age 11.3 years) received either placebo …
models. In a clinical trial, 68 myopic children (mean age 11.3 years) received either placebo …
Current and emerging pharmaceutical interventions for myopia
K Vutipongsatorn, T Yokoi… - British Journal of …, 2019 - bjo.bmj.com
Myopia is a major cause of visual impairment. Its prevalence is growing steadily, especially
in East Asia. Despite the immense disease and economic burden, there are currently no …
in East Asia. Despite the immense disease and economic burden, there are currently no …
Optical and pharmacological strategies of myopia control
P Kang - Clinical and Experimental Optometry, 2018 - Taylor & Francis
Recent increases in global myopia prevalence rates have raised significant concerns as
myopia increases the lifelong risk of various sight‐threatening ocular conditions. This …
myopia increases the lifelong risk of various sight‐threatening ocular conditions. This …
Treatment options for myopia
J Gwiazda - Optometry and Vision Science, 2009 - journals.lww.com
Myopia is a significant public health problem and its prevalence may be increasing over
time. The main treatment options of single vision spectacle lenses, contact lenses, and …
time. The main treatment options of single vision spectacle lenses, contact lenses, and …
[PDF][PDF] Is it possible to slow the progression of myopia?
SM Saw, TY Wong - ANNALS-ACADEMY OF MEDICINE …, 2004 - annals.edu.sg
The rates of myopia, including high myopia [spherical equivalent≥-6 dioptres (D)], have
been reported to be rising to epidemic proportions in Asia and solutions to this huge public …
been reported to be rising to epidemic proportions in Asia and solutions to this huge public …
Pharmaceutical intervention for myopia control
P Ganesan, CF Wildsoet - Expert review of ophthalmology, 2010 - Taylor & Francis
Myopia is the result of a mismatch between the optical power and the length of the eye, with
the latter being too long. Driving the research in this field is the need to develop myopia …
the latter being too long. Driving the research in this field is the need to develop myopia …
Update on myopia
N Warner - Current opinion in ophthalmology, 2016 - journals.lww.com
Update on myopia : Current Opinion in Ophthalmology Update on myopia : Current Opinion in
Ophthalmology Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts …
Ophthalmology Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts …